Mylan’s stock has fallen by more than three-fourths in the last 4 years. The company announced a merger with UpJohn this year, and the market received it well. Investors need to make decisions around ...
Their merger isn't official yet, but a new logo is ready to go. Mylan and Pfizer's Upjohn unit unveiled new branding for the to-be-combined company, dubbed Viatris, on Thursday with a tri-color scheme ...
The early reaction to the pairing of generic drug maker Mylan Laboratories and Pfizer’s generics unit, Upjohn — officially announced Monday — is that it’s great for Mylan but maybe not so amazing for ...
Finding the perfect name is no easy task for a new company, particularly in the exotic world of biopharma monikers. Mylan and Pfizer's Upjohn, working to close their generics megamerger, believe they ...
PITTSBURGH (KDKA/AP) -- Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business. The Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results